Hazelview Securities’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Buy
+152,424
New +$3.02M 0.43% 33
2026
Q1
Sell
-13,920
Closed -$267K 52
2025
Q4
$267K Buy
+13,920
New +$258K 0.05% 40
2018
Q4
Sell
-109,237
Closed -$2.53M 44
2018
Q3
$2.53M Sell
109,237
-189,529
-63% -$4.29M 0.6% 43
2018
Q2
$6.5M Buy
298,766
+269,019
+904% +$5.25M 1.44% 33
2018
Q1
$525K Sell
29,747
-255,857
-90% -$4.51M 0.27% 31
2017
Q4
$5.36M Sell
285,604
-136,206
-32% -$2.71M 1.57% 26
2017
Q3
$9.26M Buy
421,810
+266,009
+171% +$6.01M 2.78% 18
2017
Q2
$3.75M Buy
155,801
+81,044
+108% +$2.06M 1.17% 31
2017
Q1
$2.09M Buy
+74,757
New +$1.96M 0.8% 38

Other funds holding SBRA

Hazelview Securities's SBRA Position: Q2 2026 in Review

Hazelview Securities opened a new position in Sabra Healthcare REIT (SBRA) in Q2 2026: 152,424 shares worth $3.07M. The stake represents 0.43% of the portfolio and ranks #33 among its holdings. This is a return to the name: Hazelview Securities previously reported a position in SBRA as recently as Q4 2025.

Hazelview Securities first reported a position in SBRA in Q1 2017 and has held it in 9 quarters since. The position peaked at $9.26M in Q3 2017. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Hazelview Securities held 152,424 shares of Sabra Healthcare REIT worth $3.07M as of Q2 2026.
  • Sabra Healthcare REIT was a new Hazelview Securities position in Q2 2026.
  • Sabra Healthcare REIT made up 0.43% of Hazelview Securities's portfolio in Q2 2026, its #33 holding.
  • Hazelview Securities first reported a position in Sabra Healthcare REIT in Q1 2017 and has held it in 9 quarters since.
  • Hazelview Securities's Sabra Healthcare REIT position peaked at $9.26M in Q3 2017.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Hazelview Securities's 13F filing for Q2 2026, filed 14 Aug 2026.